Click here for the Friday Reading Search, a searchable archive of reading and knowledge resources

Since March 2020, Airmic has been issuing Friday Reading, a curated series of readings and knowledge resources sent by email to Airmic members. The objective of Airmic Friday Reading was initially to keep members informed during the Covid-19 pandemic. Today, Airmic Friday Reading has evolved in scope to include content on a wide range of subjects with each email edition following a theme. This page is a searchable archive of all the readings and knowledge resources that have been shared.

To select multiple categories and/or keywords, use Ctrl+Click (or +Click on a Mac).
McKinsey & Co, 12th November 2020
Friday Reading Edition 34 (13th November 2020)
While the COVID-19 pandemic has placed unparalleled demands on modern healthcare systems, the industry’s response has vividly demonstrated its resilience and ability to bring innovations to market quickly.
Categories:
The Royal Society, 10th November 2020
Friday Reading Edition 34 (13th November 2020)
An 80% take up of a COVID-19 vaccine could be necessary to protect the community. But given the scale and complexity of the task, vaccines will not be a silver bullet, according to this report.
Categories:
Financial Times, 9th November 2020
Friday Reading Edition 34 (13th November 2020)
[Subscription required] News on the Pfizer and BioNTech vaccine announcement, and other details.
Categories:
Keywords:
AXA XL, 23rd September 2020
Friday Reading Edition 34 (13th November 2020)
On a new Lloyd's Syndicate that will insure the transportation and storage of COVID-19 vaccines—once developed and approved for use—in emerging market countries. This highly collaborative undertaking harnesses the collective capabilities, expertise and resources of several public, private and non-profit organisations, including AXA XL.
Categories:
Keywords:
Wellcome Trust
Friday Reading Edition 34 (13th November 2020)
On the Wellcome Trust’s work in supporting the development of new and improved vaccines, as well as enabling better and broader use of the vaccines that already exist.
Categories:
Keywords: